March 25, 2020 Precision NanoSystems announces partnership with Fujifilm for the development and GMP manufacturing of nanoparticle based therapeutics Vancouver BC, March 23, 2020 Precision Nanosystems, Inc. (PNI), a global leader in enabling transformative nanomedicines announced today that the
March 23, 2020 Immediate COVID-19 Vaccine & Therapeutic Fill/Finish Production Availability Announced by Argonaut Manufacturing Services Advanced Facility Readies to Combat COVID-19 (Carlsbad, CA) March 23, 2020 – Argonaut Manufacturing Services announced today it has immediate
March 16, 2020 Asuragen Develops Armored RNA Quant® SARS-CoV-2 Control New reference material aims to facilitate and expedite global efforts to detect the novel coronavirus AUSTIN, Texas–(BUSINESS WIRE)– Asuragen, Inc.
February 27, 2020 RareCyte announces the first blood-to-result PD-L1 Circulating Tumor Cell Assay Seattle, WA, February 27, 2020 – RareCyte announces a new liquid biopsy blood test for programmed death-ligand 1 (PD-L1), enabling
February 26, 2020 Active Motif clones, sequences and expresses the first full human antibody derived from patients infected with the 2019 Coronavirus COVID-19 Active Motif Shanghai (a subsidiary of Active Motif, Inc.), in collaboration with Fudan University and its affiliated Public Health Clinical
February 22, 2020 FDA Authorizes Marketing of the First Genetic Test to Aid in the Diagnosis of Fragile X Syndrome The U.S. Food and Drug Administration today authorized marketing of the first test to detect a genetic condition known as
February 19, 2020 Nimble Announces Collaboration with Genentech to Discover and Develop Novel Peptide-Based Therapeutics MADISON, WI–Nimble Therapeutics, Inc. today announced a multi-year collaboration with Genentech, a member of the Roche Group, to accelerate discovery
January 14, 2020 Carterra® Closes Financing Round For Continued Growth of the LSA® Platform for Next Generation Antibody Discovery Additional Resources Will Support New Product Development and Global Expansion SALT LAKE CITY, UTAH, USA (January 14, 2020) – Carterra®
December 19, 2019 RareCyte Closes $22M Financing for Global Commercialization and Platform Expansion into Tissue Multiplexing SEATTLE, Dec. 19, 2019 /PRNewswire/ — RareCyte, Inc. (“RareCyte” or “the Company”) a Life Sciences company creating liquid and tissue
December 9, 2019 GEDmatch Partners with Genomics Firm SAN DIEGO, CA (December 9, 2019) — GEDmatch, a pioneer in consumer genealogy, today announced that it has joined with